U.S. Tech Hardware Stock News

NasdaqGS:PSKY
NasdaqGS:PSKYMedia

Paramount Skydance (PSKY) Q4 Loss Of US$573 Million Tests Bullish Turnaround Narrative

Paramount Skydance (PSKY) FY 2025 earnings snapshot Paramount Skydance (PSKY) has wrapped up FY 2025 with Q4 revenue of about US$8.1 billion and a basic EPS loss of US$0.52, as full year trailing twelve month figures show revenue of roughly US$28.9 billion alongside a basic EPS loss of US$0.55. Over recent quarters, revenue has moved from US$6.7 billion in Q3 2024 to US$8.1 billion in Q4 2025. Quarterly EPS has ranged from a profit of US$0.23 in Q1 2025 to losses of US$0.28 and US$0.52 in Q3...
NasdaqGS:OPCH
NasdaqGS:OPCHHealthcare

Option Care Health Growth Story Faces Debt And Biosimilar Pressures

Option Care Health reported strong 2025 results, with significant revenue growth and expanded service offerings across its infusion network. The company increased its footprint of infusion suites and invested in automation and AI to support operational efficiency. Management highlighted disciplined capital allocation, including targeted M&A, while managing headwinds from biosimilar conversions and reimbursement pressures. Option Care Health (NasdaqGS:OPCH) is coming off a year of solid...
NYSE:OTIS
NYSE:OTISMachinery

How Otis Worldwide’s Phased IoT Elevator Upgrades At Otis Worldwide (OTIS) Has Changed Its Investment Story

In February 2026, Otis Worldwide introduced its Arise MOD Prime and Arise MOD Plus elevator modernization packages in North America, targeting low- to mid-rise residential and commercial buildings with flexible, phased upgrade options. The new Arise MOD offerings combine safety, energy efficiency, and IoT-based monitoring, giving building owners more control over modernization scope, timing, and cost while addressing issues tied to aging elevator infrastructure. We’ll now examine how this...
NYSE:GNL
NYSE:GNLREITs

Global Net Lease (GNL) Q4 FFO Loss Challenges Income-Focused Bull Narratives

Latest FY 2025 Earnings Snapshot Global Net Lease (GNL) has just wrapped up FY 2025 with fourth quarter revenue of US$116.9 million and basic EPS of US$0.20, while funds from operations came in at a loss of US$52.3 million, setting a mixed tone for income focused REIT investors watching the headline numbers. Over recent quarters the company has seen revenue move from US$199.1 million in Q4 2024 to US$132.4 million in Q1 2025, US$124.9 million in Q2 2025, US$121.0 million in Q3 2025 and...
NasdaqGM:TRDA
NasdaqGM:TRDABiotechs

Entrada Therapeutics (TRDA) Quarterly Revenue Slump Tests Bullish Growth Narratives

Entrada Therapeutics (TRDA) closed out FY 2025 with Q4 revenue of US$1.3 million and a basic EPS loss of US$0.94, while trailing twelve month figures showed revenue of US$25.4 million and a basic EPS loss of US$3.47. Over the past few quarters, the company has seen quarterly revenue move from US$37.4 million in Q4 2024 to US$20.6 million in Q1 2025, then to US$1.9 million, US$1.6 million and US$1.3 million in Q2, Q3 and Q4 2025. Basic EPS shifted from a profit of US$0.03 in Q4 2024 to losses...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu (NasdaqGS:BIDU) One Off C¥19.6b Loss Challenges Earnings Narrative

Baidu (NasdaqGS:BIDU) has wrapped up FY 2025 with fourth quarter revenue of C¥32.7b and basic EPS of C¥5.24, capping a year in which trailing twelve month revenue came in at C¥129.1b and basic EPS at C¥16.40. Over recent quarters the company has seen quarterly revenue move between C¥32.5b and C¥32.7b, while basic EPS has ranged from a loss of C¥33.12 in Q3 2025 to C¥22.44 in Q1 2025. This has occurred alongside a trailing net profit margin of 6.4% compared with 15.3% a year earlier, which...
NasdaqGS:ALEC
NasdaqGS:ALECBiotechs

Alector (ALEC) Posts Steep US$37 Million Quarterly Loss Testing Bullish Pipeline Narratives

Alector (ALEC) has laid out its FY 2025 story with fourth quarter revenue of US$6.2 million, a basic EPS loss of US$0.34 and net income loss of US$37.3 million, set against trailing 12 month revenue of US$21.0 million and a full year EPS loss of US$1.39 on a US$142.9 million net loss. Over recent quarters, the company has seen revenue move between US$3.3 million and US$7.9 million with basic EPS losses ranging from US$0.30 to US$0.41 per quarter, while the prior year fourth quarter showed...
NasdaqGM:RXST
NasdaqGM:RXSTMedical Equipment

RxSight (RXST) Loss Deepens In Q4 Results Reinforcing Bearish Profitability Narratives

RxSight (RXST) has just reported its FY 2025 numbers with Q4 revenue of US$32.6 million and a basic EPS loss of US$0.22, while on a trailing twelve month basis revenue was US$134.5 million and basic EPS was a loss of US$0.95, keeping the focus firmly on how quickly the business can scale toward profitability. Over the past few quarters, the company has seen revenue range from US$30.3 million to US$40.2 million and basic EPS losses move between US$0.15 and US$0.29, which puts a spotlight on...
NYSE:HCI
NYSE:HCIInsurance

HCI Group (HCI) Combined Ratio Improvement Reinforces Bullish Underwriting Narratives

HCI Group (HCI) has capped FY 2025 with fourth quarter revenue of US$246.2 million and basic EPS of US$7.50, rounding out a year where trailing twelve month revenue reached US$900.9 million and EPS came in at US$24.58. Over the past few quarters, the company has seen revenue move from US$161.9 million and EPS of roughly US$0.22 in Q4 2024 to US$216.4 million and EPS of US$6.47 in Q1 2025, US$221.9 million and EPS of US$6.08 in Q2, and US$216.4 million with EPS of about US$5.06 in Q3. This...
NYSE:QXO
NYSE:QXOTrade Distributors

QXO (QXO) Q4 Loss Narrows To US$90.2m Testing Bearish Profitability Narratives

QXO (QXO) has just reported its FY 2025 numbers, with Q4 revenue of US$2.2 billion and a basic EPS loss of US$0.13 per share on net income excluding extra items of a US$90.2 million loss. Over recent quarters the company has seen revenue move from US$13.5 million and EPS of US$0.03 loss in Q1 2025 to US$2.7 billion and EPS of US$0.24 loss in Q3 2025, before landing at US$2.2 billion and EPS of US$0.13 loss in Q4. Trailing twelve month revenue sits at US$6.8 billion and EPS at US$0.46 loss,...
NasdaqGS:CARL
NasdaqGS:CARLMedical Equipment

Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives

Carlsmed (CARL) has reported its FY 2025 fourth quarter with total revenue of US$15.2 million and a basic EPS loss of US$0.32, while on a trailing twelve month basis revenue was US$50.5 million and basic EPS was a loss of US$2.12. The company has seen quarterly revenue move from US$9.4 million in Q4 2024 to US$15.2 million in Q4 2025, as basic EPS shifted from a loss of US$1.14 to a loss of US$0.32 over the same period, setting up a story where faster top line expansion is still being weighed...
NasdaqGS:SPOK
NasdaqGS:SPOKWireless Telecom

Spok Holdings (SPOK) Dividend Coverage Concerns Reinforce Bearish Narratives Despite 10.49% Yield

Spok Holdings (SPOK) has wrapped up FY 2025 with fourth quarter revenue of US$33.9 million and basic EPS of US$0.14, while trailing 12 month revenue sits at US$139.7 million and EPS at US$0.77. Over the past six quarters, the company has seen quarterly revenue move in a tight band between US$33.9 million and US$36.3 million. Basic EPS has ranged from US$0.14 to US$0.25, and trailing 12 month EPS has edged from US$0.73 to US$0.81 before landing at US$0.77 most recently. With net profit margins...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

GoodRx Holdings GDRX Margin Improvement Reinforces Bullish Profitability Narratives

GoodRx Holdings (GDRX) FY 2025 Earnings Snapshot GoodRx Holdings (GDRX) closed out FY 2025 with Q4 revenue of US$194.8 million and basic EPS of US$0.02. Trailing twelve month figures came in at US$796.9 million of revenue and EPS of US$0.09 on net income of US$30.4 million. The company has seen quarterly revenue move from US$198.6 million in Q4 2024 to a range of US$195.3 million to US$203.1 million through 2025, with EPS running between US$0.00 and US$0.04 across those same periods. With...
NYSE:AI
NYSE:AISoftware

C3.ai (AI) Q3 Loss Worsening To US$0.94 EPS Reinforces Bearish Profitability Concerns

C3.ai (AI) just posted its Q3 2026 numbers, with revenue of US$53.3 million and a basic EPS loss of US$0.94, while trailing twelve month revenue came in at US$307.4 million and EPS at a loss of US$3.17. Over the last six reported quarters, the company has seen quarterly revenue move from US$94.3 million in Q2 2025 to US$53.3 million in Q3 2026, with basic EPS losses ranging between US$0.52 and US$0.94. This sets up an earnings story that is centered on loss-making margins and the pace at...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

PROCEPT BioRobotics (PRCT) Quarterly Loss Deepens Challenging Bullish Margin Expansion Narrative

PROCEPT BioRobotics (PRCT) just closed out FY 2025 with Q4 revenue of US$76.4 million and a basic EPS loss of US$0.53. The company also reported a trailing 12 month revenue base of US$308.1 million and an EPS loss of US$1.72. Over recent periods, quarterly revenue has moved from US$58.4 million in Q3 2024 to US$68.2 million in Q4 2024, then to US$69.2 million in Q1 2025, US$79.2 million in Q2 2025, US$83.3 million in Q3 2025, and US$76.4 million in Q4 2025. Over the same stretch, quarterly...
NYSE:MIAX
NYSE:MIAXCapital Markets

Miami International Holdings Q4 Profit Rebound Tests Bullish Earnings Recovery Narrative

Miami International Holdings FY 2025 earnings snapshot Miami International Holdings (MIAX) has reported a mixed FY 2025 finish, with fourth quarter revenue of US$369.4 million and EPS of US$0.34. The trailing twelve months still reflect a loss of US$70.0 million on revenue of US$1.4 billion and a TTM EPS loss of US$0.82. In recent quarters the company’s quarterly revenue moved from US$323.9 million in Q4 2024 to US$369.4 million in Q4 2025, while EPS shifted from US$0.05 in Q4 2024 to US$0.34...
NasdaqGS:SFNC
NasdaqGS:SFNCBanks

Simmons First National (SFNC) Net Interest Margin Rebound Tests Bearish Profitability Narratives

Simmons First National (SFNC) closed out FY 2025 with fourth quarter revenue of US$233.9 million and basic EPS of US$0.54, following a turbulent year in which trailing twelve month figures show revenue of US$37.4 million and a basic EPS loss of US$2.96. Over recent quarters, the company has seen quarterly revenue move from US$162.7 million in Q3 2024 to US$195.2 million in Q4 2024, then to US$182.8 million, US$202.2 million and US$233.9 million through Q1 to Q4 2025. Basic EPS shifted from...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

Chime Financial (CHYM) Q2 Loss Of US$923m Fuels Bearish Profitability Narratives

Chime Financial (CHYM) closed out FY 2025 with Q4 revenue of US$596.4 million and a basic EPS loss of US$0.12. Trailing 12 month figures show revenue of about US$2.2 billion and a basic EPS loss of US$4.27, keeping the story firmly in loss-making territory. Over recent periods the company has seen revenue move from US$475.2 million in Q4 2024 to US$596.4 million in Q4 2025. This has come alongside quarterly EPS that has swung between a profit of US$0.20 in Q1 2025 and a loss of US$7.29 in Q2...
NYSE:UHS
NYSE:UHSHealthcare

Universal Health Services Q4 EPS Strength Reinforces Bullish Margin Narrative

Universal Health Services (UHS) has wrapped up FY 2025 with fourth quarter revenue of US$4.5b and basic EPS of US$7.19, backed by net income of US$445.9m. The company has seen quarterly revenue move from US$4.1b in Q4 2024 to US$4.5b in Q4 2025, while basic EPS stepped up from US$5.07 to US$7.19 over the same period. On a trailing twelve month view, net profit margin sits at 8.6% versus 7.2% a year earlier, giving investors a clearer view of how earnings are converting into profit. See our...
NYSE:CWT
NYSE:CWTWater Utilities

California Water Service Group (CWT) Margin Compression Tests Bullish Earnings Narrative

California Water Service Group (CWT) has just wrapped up FY 2025 with fourth quarter revenue of US$220 million and basic EPS of US$0.19, alongside net income of US$11.5 million. The company has seen quarterly revenue move from US$222 million and EPS of US$0.33 in Q4 2024 to US$220 million and EPS of US$0.19 in Q4 2025. On a trailing 12 month basis, EPS was US$2.15 on revenue of about US$1.0 billion and net income of US$128.2 million, setting up a story where investors are weighing earnings...
NYSE:QSR
NYSE:QSRHospitality

Restaurant Brands Investor Day Clarifies Growth Targets And Simplification Plan

Restaurant Brands International held its 2026 Investor Day, offering a midpoint update on its long-term plan. The company reaffirmed its multiyear growth targets and detailed progress on its existing initiatives. Management outlined a roadmap to simplify its structure, including plans to sunset the Restaurant Holdings segment by 2027. The event also highlighted priorities for capital allocation and operational focus over the medium term. Restaurant Brands International, traded as NYSE:QSR,...
NasdaqCM:MDXG
NasdaqCM:MDXGBiotechs

MiMedx Group (MDXG) Revenue Jump To US$118.1 Million Tests Slow Growth Narrative

MiMedx Group (MDXG) has wrapped up FY 2025 with fourth quarter revenue of about US$118.1 million and basic EPS of roughly US$0.10, while trailing twelve month figures sit at around US$418.6 million of revenue and US$0.33 of basic EPS. Over the past few quarters, the company has seen revenue move from US$84.1 million in Q3 2024 to US$92.9 million in Q4 2024 and then to US$118.1 million in Q4 2025, with quarterly basic EPS ranging from about US$0.05 to US$0.11 across that stretch. With a...
NasdaqGS:GERN
NasdaqGS:GERNBiotechs

Geron (GERN) Q4 Loss Of US$31.1 Million Tests Bullish Profitability Narrative

Geron (GERN) has just posted its FY 2025 results, with Q4 total revenue of US$48.0 million and a basic EPS loss of US$0.05, alongside trailing twelve month revenue of US$183.9 million and a TTM basic EPS loss of US$0.13. Over recent periods the company has seen quarterly revenue move between US$39.6 million and US$49.0 million, while basic EPS losses have ranged from US$0.02 to US$0.05 per quarter. This sets the backdrop for how investors assess the current TTM net loss of US$85.8 million and...